We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$130M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow
% of AUM
99.51%
Top 10 Holdings %
Top 10 Hldgs %
26.7%
Holding
143
New
142
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.91M |
| 2 |
GE Aerospace
GE
|
+$3.91M |
| 3 |
BK Technologies
BKTI
|
+$3.82M |
| 4 |
GEN MOTORS CORP
GM
|
+$3.65M |
| 5 |
Devon Energy
DVN
|
+$3.33M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.14% |
| 2 | Technology | 12.74% |
| 3 | Energy | 11.84% |
| 4 | Real Estate | 10.25% |
| 5 | Healthcare | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Redwood Trust
RWT
$371M
| $1.51M | 1.16% |
+88,600
| New | +$1.83M |
2013 Q2
0 quarters
|
|
|
DNY
27
DELISTED
DONNELLEY R R & SONS CO
DNY
| $1.39M | 1.07% |
+99,000
| New | +$1.39M |
2013 Q2
0 quarters
|
|
28
MFA Financial
MFA
$661M
| $1.32M | 1.02% |
+39,150
| New | +$1.41M |
2013 Q2
0 quarters
|
|
29
Wendy's
WEN
$1.18B
| $1.31M | 1.01% |
+224,750
| New | +$1.3M |
2013 Q2
0 quarters
|
|
30
Arbor Realty Trust
ABR
$504M
| $1.31M | 1.01% |
+208,410
| New | +$1.49M |
2013 Q2
0 quarters
|
|
31
Center Bancorp
CNOB
$1.49B
| $1.3M | 1% |
+102,554
| New | +$1.27M |
2013 Q2
0 quarters
|
|
32
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$578M
| $1.2M | 0.93% |
+55,452
| New | +$1.28M |
2013 Q2
0 quarters
|
|
33
iShares S&P 100 ETF
OEF
$20.7B
| $1.16M | 0.9% |
+16,180
| New | +$1.18M |
2013 Q2
0 quarters
|
|
|
SSW.PRC
34
DELISTED
SEASPAN CORP 9.50% SER C RED PERP PFD SHS (MHL)
SSW.PRC
| $1.11M | 0.86% |
+41,157
| New | +$1.14M |
2013 Q2
0 quarters
|
|
|
RLH
35
DELISTED
Red Lions Hotel Corporation
RLH
| $1.09M | 0.84% |
+179,137
| New | +$1.15M |
2013 Q2
0 quarters
|
|
36
Vodafone
VOD
$35.4B
| $1.03M | 0.79% |
+35,120
| New | +$1.05M |
2013 Q2
0 quarters
|
|
37
Sprott Physical Gold
PHYS
$14.6B
| $1.03M | 0.79% |
+100,800
| New | +$1.19M |
2013 Q2
0 quarters
|
|
38
Merck
MRK
$358B
| $1.01M | 0.78% |
+22,846
| New | +$1.02M |
2013 Q2
0 quarters
|
|
39
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.01M | 0.78% |
+102,200
| New | +$1.07M |
2013 Q2
0 quarters
|
|
40
Ford
F
$47.5B
| $979K | 0.76% |
+63,300
| New | +$908K |
2013 Q2
0 quarters
|
|
41
Ovintiv
OVV
$18.5B
| $947K | 0.73% |
+11,180
| New | +$1.04M |
2013 Q2
0 quarters
|
|
42
Western Union
WU
$1.87B
| $909K | 0.7% |
+53,100
| New | +$841K |
2013 Q2
0 quarters
|
|
43
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
| $905K | 0.7% |
+23,280
| New | +$845K |
2013 Q2
0 quarters
|
|
|
TRIB
44
Trinity Biotech
TRIB
$5.55M
| $869K | 0.67% |
+344
| New | +$856K |
2013 Q2
0 quarters
|
|
45
Newmont
NEM
$117B
| $860K | 0.66% |
+28,700
| New | +$964K |
2013 Q2
0 quarters
|
|
46
Norfolk Southern
NSC
$71.8B
| $846K | 0.65% |
+11,650
| New | +$889K |
2013 Q2
0 quarters
|
|
|
CHL
47
DELISTED
China Mobile Limited
CHL
| $846K | 0.65% |
+16,350
| New | +$864K |
2013 Q2
0 quarters
|
|
48
Sarepta Therapeutics
SRPT
$1.77B
| $839K | 0.65% |
+22,050
| New | +$789K |
2013 Q2
0 quarters
|
|
49
Corning
GLW
$125B
| $834K | 0.64% |
+58,600
| New | +$852K |
2013 Q2
0 quarters
|
|
50
Healthpeak Properties
DOC
$13B
| $811K | 0.63% |
+19,599
| New | +$894K |
2013 Q2
0 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Benchmark Capital Advisors, which disclosed 143 positions worth $130M. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Pfizer: 141,552 shares worth $3.76M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Technology and Energy.
- Benchmark Capital Advisors's largest Q2 2013 buy was Pfizer: 141,552 shares worth $3.76M.
- Benchmark Capital Advisors's ten largest holdings make up 27% of its $130M portfolio in Q2 2013.
- Benchmark Capital Advisors disclosed 143 positions in Q2 2013, its first 13F filing on record.
Based on Benchmark Capital Advisors's 13F filing for Q2 2013, filed 15 Aug 2013.